Journal
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume 97, Issue 10, Pages 3759-3765Publisher
ENDOCRINE SOC
DOI: 10.1210/jc.2012-2037
Keywords
-
Categories
Funding
- Fondazione Diabete e Ricerca (ONLUS) of Societa Italiana di Diabetologia
- Novo Nordisk, Italy
Ask authors/readers for more resources
Context: Latent auto immune diabetes in adults(LADA) includes a heterogeneous population wherein, based on glutamic acid decarboxylase antibody (GADA) titer, different subgroups of subjects can be identified. Objective: The aim of the present study was to evaluate GADA titer-related risk for beta-cell and other organ-specific autoimmunity in LADA subjects. Methods: Adult-onset autoimmune diabetes subjects (n = 236) and type 2 diabetes (T2DM) subjects (n = 450) were characterized for protein tyrosine phosphatase (IA-2(IC) and IA-2(256-760)), zinc transporter 8 (ZnT8), thyroid peroxidase, (TPO), steroid 21-hydroxylase (21-OH), tissue transglutaminase (tTG), and antiparietal cell (APC) antibodies. Results: High GADA titer compared to low GADA titer showed a significantly higher prevalence of IA-2(IC), IA-2(256-760), ZnT8, TPO, and APC antibodies (P <= 0.04 for all comparison). 21-OH antibodies were detected in 3.4% of high GADA titer. A significant decreasing trend was observed from high GADA to low GADA and to T2DM subjects for IA-2(256-760), ZnT8, TPO, tTG, and APC antibodies (P for trend < 0.001). TPO was the only antibody showing a different prevalence between gender; low GADA titer and T2DM female patients had a higher frequency of TPO antibody compared to males (P = 0.0004 and P = 0.0006, respectively), where the presence of high GADA titer conferred an odds ratio of 8.6 for TPO compared to low GADA titer. After subdividing high and low GADA titer subjects according to the number of antibodies, we observed that 73.3% of high GADA titer subjects were positive for at least one or more antibodies, compared to 38.3% of low GADA titer (P < 0.0001). Conclusions: In LADA subjects, high GADA titer was associated with a profile of more severe autoimmunity and, in male gender, specifically predisposed to thyroid autoimmunity. A regular screening for other antibodies is recommended in LADA patients according to GADA titer and gender. (J Clin Endocrinol Metab 97: 3759-3765, 2012)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available